An unlimited scope for novel formulations as orally disintegrating systems: Present and future prospects.
| dc.contributor.author | Thakur, Reeta Rani | |
| dc.contributor.author | Kashi, Mridul | |
| dc.date.accessioned | 2014-05-12T04:24:12Z | |
| dc.date.available | 2014-05-12T04:24:12Z | |
| dc.date.issued | 2011-03 | |
| dc.description.abstract | An orally disintegrating tablet or orodispersible tablet (ODT) is a drug dosage form available for a limited amount of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphasia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Common among all age groups, dysphasia is observed in about 35% of the general population, as well as up to 60% of the elderly institutionalized population and 18-22% of all patients in long-term care facilities. During the last decade, ODTs have become available in a variety of therapeutic markets, both OTC and by prescription. An additional reason to use ODTs is the convenience of a tablet that can be taken without water. | en_US |
| dc.identifier.citation | Thakur Reeta Rani, Kashi Mridul. An unlimited scope for novel formulations as orally disintegrating systems: Present and future prospects. Journal of Applied Pharmaceutical Science. 2011 Mar; 1(1): 13-19. | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/150731 | |
| dc.language.iso | en | en_US |
| dc.source.uri | https://www.japsonline.com/counter.php?aid=4 | en_US |
| dc.subject | ODT | en_US |
| dc.subject | Disintegration | en_US |
| dc.subject | Dissolution test | en_US |
| dc.subject | Oral dispersible tablets | en_US |
| dc.title | An unlimited scope for novel formulations as orally disintegrating systems: Present and future prospects. | en_US |
| dc.type | Article | en_US |